Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03240653 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gaucherite - A Study to Stratify Gaucher Disease

Study acronym: Gaucherite
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: 4 to 7v8
  2. Enrollment target: 280 to 250
    • Site contacts updated at 1 of 8 sites
    • Publications: 2 to 4
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Sep 30, 2019 to Sep 30, 2028
    • Study completion date: Sep 30, 2029 to Dec 31, 2028
    • Study arms: 3 to 2
    • Study description shortened, about 4 words
    v5
  5. Enrollment target: 250 to 280v4 Show 5 more changesShow less
    • Study completion date: Sep 30, 2020 to Sep 30, 2029
    • Secondary endpoints: 7 to 8
    • Site details revised at 1 of 8 sites
    • Study arms: 2 to 3
    • Eligibility criteria shortened, about 5 words
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Sep 30, 2017 to Sep 30, 2019v3
  2. Primary endpoints revised (9)v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research is to review data already collected and to collect new data from adults and children in England with Gaucher Disease to determine clinical factors which predict severity and response to therapy of Gaucher disease especially in the areas of bone, cancer and brain conditions.
Trial Details
NCT Number NCT03240653
Lead Sponsor Cambridge University Hospitals NHS Foundation Trust
Collaborators: Medical Research Council, National Institute for Health Research, United Kingdom
Conditions
(from sponsor)		 Gaucher Disease, Type I, Gaucher Disease, Type III
Related terms Gaucher Disease
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov